US 10,828,310 B2
Reducing the risk of cardiovascular eventsGeneral
US 10,828,310 B2
Reducing the risk of cardiovascular events
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Marcos L Sznaidman
Art Unit:
1628 Organic Chemistry
Agent:
Inventors:
Frank Misselwitz; Stuart J. Connolly; Nancy Cook Bruns; John William Andrew Eikelboom; Salim Yusuf
Assignee:
Priority:
02/02/18
Filed:
01/31/19
Granted:
11/10/20
Expiration:
02/02/38
Abstract
Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.
Cooperative Patent Classification (CPC)
A61A61K31/5377A61P9/10A61K